Clinical trial NCT00036439 - References

Ulcerative Colitis — A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

Citation(s)

•   Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, Bala M, Johanns J, Olson A, Hanauer SB
  The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol. 2007 Apr;102(4):794-802. E
•   Reinisch W, Sandborn WJ, Bala M, Yan S, Feagan BG, Rutgeerts P, Radford-Smith G, Xu S, Eisenberg D, Olson A, Colombel JF
  Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity
•   Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF
  Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl

A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis

Details for clinical trial NCT00036439